It is not necessarily YY1 - The frequently forgotten Yin-Yang-2 transcription factor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 52, 2010, Pages

  Klar, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR YY1; TRANSCRIPTION FACTOR YY2; UNCLASSIFIED DRUG; VASCULOTROPIN;

CANCER THERAPY; CHROMATIN IMMUNOPRECIPITATION; DRUG TARGETING; LETTER; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CXCR4; RNA INTERFERENCE; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS; YY1 TRANSCRIPTION FACTOR;

EID: 78651093252     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011338108     Document Type: Letter

References (5)

1. de Nigris F, et al. (2010) CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci USA 107:14484-14489.
2. Klar M, Bode J (2005) Enhanceosome formation over the beta interferon promoter underlies a remote-control mechanism mediated by YY1 and YY2. Mol Cell Biol 25: 10159-10170.
3. Drews D, Klar M, Dame C, Bräuer AU (2009) Developmental expression profile of the YY2 gene in mice. BMC Dev Biol 9:45.
4. Chen L, et al. (2010) Genome-wide analysis of YY2 versus YY1 target genes. Nucleic Acids Res 38:4011-4026.
5. Luo C, Lu X, Stubbs L, Kim J (2006) Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. Genomics 87:348-355.